comparemela.com

Already positive, the research from Barclays and its analyst Carole Madjo still consider the stock as a Buy opportunity. The target price is unchanged and still at CHF 161.

Related Keywords

Carole Madjo ,Barclays ,Markets ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.